Neurobit is a leading medical technology company that develops Software as a Medical Device (SaMD) powered by AI to decipher intricate patterns in health vitals measured during sleep, termed 'sleep biomarkers'. This technology aids in delivering tailored, predictive, and precision healthcare. With a vision to establish a universally accessible health analytics system, Neurobit aims to enhance care quality and efficiency for healthcare professionals and patients. Our Biomarker Bridge initiative is at the forefront of this mission—creating a collaborative platform that connects AI-driven biomarker companies, enabling cross-disciplinary innovation, and accelerating the integration of digital biomarkers into clinical practice. Globally, over 150 esteemed universities, hospitals, and R&D centers rely on our advanced technology solutions to push the boundaries of healthcare innovation.